» Articles » PMID: 17394180

Impact of Health Maintenance Organizations and Fee-for-service on Health Care Utilization Among People with Systemic Lupus Erythematosus

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 2007 Mar 31
PMID 17394180
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare health care utilization in people with systemic lupus erythematosus (SLE) in health maintenance organizations (HMOs) and fee-for-service (FFS).

Methods: A structured survey was administered to a cohort of 982 people with SLE who were assembled between 2002 and early 2005. A total of 2,656 person-years of observation were completed by the end of 2005. In each year, respondents reported their health care utilization and whether they had HMO or FFS coverage. We compared health care utilization of those in HMOs and FFS, with and without adjustment for socioeconomic, demographic, and health characteristics using repeated-measures regression techniques.

Results: Compared with people with SLE who were in FFS, those in HMOs were younger (3.3 years), received a diagnosis at an earlier age (3.6 years), had slightly less disease activity (0.4 on a 10-point scale), were more likely to be nonwhite (8.8%), were less likely to be below the poverty line (7.8%), and were less likely to have public insurance (29.7%). The 2 groups did not differ in other characteristics. On an unadjusted basis, subjects with SLE in HMOs had significantly fewer physician visits (3.1; 95% confidence interval [95% CI] 1.7, 4.5) and were less likely to report one or more outpatient surgical visits (6.3%; 95% CI 2.5, 10.0), and hospital admissions (5.5%; 95% CI 1.7, 9.3) than those in FFS. Adjustment reduced the differences in physician visits (2.3; 95% CI 1.1, 3.5), outpatient surgical rates (4.4%; 95% CI 0.6, 8.1), and hospital admission rates (4.0%, 95% CI 0.4, 7.7).

Conclusion: Subjects with SLE in HMOs utilized substantially less ambulatory care and were less likely to have outpatient surgery and hospital admissions than those in FFS; the effects were not completely explained by socioeconomic, demographic, and health characteristics.

Citing Articles

Characteristics and Symptom Severity of Patients Reporting Systemic Lupus Erythematosus in the PatientsLikeMe Online Health Community: A Retrospective Observational Study.

Nyman E, Vaughan T, Desta B, Wang X, Barut V, Emmas C Rheumatol Ther. 2020; 7(1):201-213.

PMID: 32008212 PMC: 7021880. DOI: 10.1007/s40744-020-00195-7.


Socioeconomic Predictors of Incident Depression in Systemic Lupus Erythematosus.

McCormick N, Trupin L, Yelin E, Katz P Arthritis Care Res (Hoboken). 2017; 70(1):104-113.

PMID: 28371529 PMC: 5617755. DOI: 10.1002/acr.23247.


Relationship Between Process of Care and a Subsequent Increase in Damage in Systemic Lupus Erythematosus.

Yelin E, Yazdany J, Trupin L Arthritis Care Res (Hoboken). 2016; 69(6):927-932.

PMID: 27477567 PMC: 5285489. DOI: 10.1002/acr.22977.


Interactions between patients, providers, and health systems and technical quality of care.

Yelin E, Yazdany J, Tonner C, Trupin L, Criswell L, Katz P Arthritis Care Res (Hoboken). 2014; 67(3):417-24.

PMID: 25132660 PMC: 4320034. DOI: 10.1002/acr.22427.


Healthcare quality in systemic lupus erythematosus: using Donabedian's conceptual framework to understand what we know.

Lawson E, Yazdany J Int J Clin Rheumtol. 2012; 7(1):95-107.

PMID: 22448191 PMC: 3308354. DOI: 10.2217/ijr.11.65.


References
1.
Stewart M, Petri M . Lupus nephritis outcomes: health maintenance organizations compared to non-health maintenance organizations. J Rheumatol. 2000; 27(4):900-2. View

2.
Yelin E, Trupin L, Katz P . Impact of managed care on the use of biologic agents for rheumatoid arthritis. Arthritis Rheum. 2005; 53(3):423-30. DOI: 10.1002/art.21178. View

3.
Miller R, Luft H . HMO plan performance update: an analysis of the literature, 1997-2001. Health Aff (Millwood). 2002; 21(4):63-86. DOI: 10.1377/hlthaff.21.4.63. View

4.
Karlson E, Daltroy L, Rivest C, Ramsey-Goldman R, Wright E, Partridge A . Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus. 2003; 12(4):280-6. DOI: 10.1191/0961203303lu332oa. View

5.
Tan E, Cohen A, Fries J, MASI A, McShane D, Rothfield N . The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25(11):1271-7. DOI: 10.1002/art.1780251101. View